BioCentury
ARTICLE | Tools & Techniques

Optimizing outreach

How Prognos’ machine learning tool matches therapies to potential patients

February 25, 2017 12:51 AM UTC

After spending six years developing and testing its technology, Prognos has officially launched its commercial tool that uses laboratory, imaging and other data to predict which patients are the best candidates for marketed therapies.

Prior to its launch in January, Prognos had been building its data registry and working with biopharma companies to test the tool, which produces weekly reports highlighting physicians with patients who are candidates for a company’s drug. ...